Cargando…

Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)

Objective: Endovascular embolization using non-adhesive agents (e.g., ethylene vinyl alcohol copolymer with suspended micronized tantalum dissolved in dimethyl sulfoxide; Squid, Balt Extrusion) is an established treatment of brain arteriovenous malformations, dural arteriovenous fistulas, and hyperv...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrov, Andrey, Ivanov, Arkady, Rozhchenko, Larisa, Petrova, Anna, Bhogal, Pervinder, Cimpoca, Alexandru, Henkes, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509410/
https://www.ncbi.nlm.nih.gov/pubmed/34640453
http://dx.doi.org/10.3390/jcm10194436
_version_ 1784582333322493952
author Petrov, Andrey
Ivanov, Arkady
Rozhchenko, Larisa
Petrova, Anna
Bhogal, Pervinder
Cimpoca, Alexandru
Henkes, Hans
author_facet Petrov, Andrey
Ivanov, Arkady
Rozhchenko, Larisa
Petrova, Anna
Bhogal, Pervinder
Cimpoca, Alexandru
Henkes, Hans
author_sort Petrov, Andrey
collection PubMed
description Objective: Endovascular embolization using non-adhesive agents (e.g., ethylene vinyl alcohol copolymer with suspended micronized tantalum dissolved in dimethyl sulfoxide; Squid, Balt Extrusion) is an established treatment of brain arteriovenous malformations, dural arteriovenous fistulas, and hypervascular neoplasms. Middle meningeal artery (MMA) embolization is a relatively new concept for treating chronic subdural hematomas (CSDH). This study aimed to evaluate the safety and effectiveness of the use of Squid in the endovascular treatment of CSDH. Methods: Embolization was offered to patients with CSDH with minimal or moderate neurological deficits and patients who had previously undergone open surgery to evacuate their CSDH without a significant effect. Distal catheterization of the MMA was followed by embolization of the hematoma capsule with Squid 12 or Squid 18. Safety endpoints were ischemic or hemorrhagic stroke and any other adverse event of the endovascular procedure. Efficacy endpoints were the feasibility of the intended procedure and a ≥ 50% reduction of the maximum depth of the CSDH confirmed by follow-up computed tomography (CT) after >3 months. Results: Between November 2019 and July 2021, 10 patients (3 female and 7 male, age range 42–89 years) were enrolled. Five patients had bilateral hematomas, and five patients had previously been operated on with no significant effect and recurrent hematoma formation. The attempted embolization was technically possible in all patients. No technical or clinical complication was encountered. During a post-procedural follow-up (median 90 days), 10 patients improved clinically. A complete resolution of the CSDH was observed in 10 patients. The clinical condition of all enrolled patients during the so-far last contact was rated mRS 0 or 1. Conclusion: A distal catheterization of the MMA for the endovascular embolization of CSDH with Squid allowed for the devascularization of the MMA and the dependent vessels of the hematoma capsule. This procedure resulted in a partial or complete resolution of the CSDH. Procedural complications were not encountered.
format Online
Article
Text
id pubmed-8509410
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85094102021-10-13 Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid) Petrov, Andrey Ivanov, Arkady Rozhchenko, Larisa Petrova, Anna Bhogal, Pervinder Cimpoca, Alexandru Henkes, Hans J Clin Med Article Objective: Endovascular embolization using non-adhesive agents (e.g., ethylene vinyl alcohol copolymer with suspended micronized tantalum dissolved in dimethyl sulfoxide; Squid, Balt Extrusion) is an established treatment of brain arteriovenous malformations, dural arteriovenous fistulas, and hypervascular neoplasms. Middle meningeal artery (MMA) embolization is a relatively new concept for treating chronic subdural hematomas (CSDH). This study aimed to evaluate the safety and effectiveness of the use of Squid in the endovascular treatment of CSDH. Methods: Embolization was offered to patients with CSDH with minimal or moderate neurological deficits and patients who had previously undergone open surgery to evacuate their CSDH without a significant effect. Distal catheterization of the MMA was followed by embolization of the hematoma capsule with Squid 12 or Squid 18. Safety endpoints were ischemic or hemorrhagic stroke and any other adverse event of the endovascular procedure. Efficacy endpoints were the feasibility of the intended procedure and a ≥ 50% reduction of the maximum depth of the CSDH confirmed by follow-up computed tomography (CT) after >3 months. Results: Between November 2019 and July 2021, 10 patients (3 female and 7 male, age range 42–89 years) were enrolled. Five patients had bilateral hematomas, and five patients had previously been operated on with no significant effect and recurrent hematoma formation. The attempted embolization was technically possible in all patients. No technical or clinical complication was encountered. During a post-procedural follow-up (median 90 days), 10 patients improved clinically. A complete resolution of the CSDH was observed in 10 patients. The clinical condition of all enrolled patients during the so-far last contact was rated mRS 0 or 1. Conclusion: A distal catheterization of the MMA for the endovascular embolization of CSDH with Squid allowed for the devascularization of the MMA and the dependent vessels of the hematoma capsule. This procedure resulted in a partial or complete resolution of the CSDH. Procedural complications were not encountered. MDPI 2021-09-27 /pmc/articles/PMC8509410/ /pubmed/34640453 http://dx.doi.org/10.3390/jcm10194436 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Petrov, Andrey
Ivanov, Arkady
Rozhchenko, Larisa
Petrova, Anna
Bhogal, Pervinder
Cimpoca, Alexandru
Henkes, Hans
Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title_full Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title_fullStr Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title_full_unstemmed Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title_short Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid)
title_sort endovascular treatment of chronic subdural hematomas through embolization: a pilot study with a non-adhesive liquid embolic agent of minimal viscosity (squid)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509410/
https://www.ncbi.nlm.nih.gov/pubmed/34640453
http://dx.doi.org/10.3390/jcm10194436
work_keys_str_mv AT petrovandrey endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT ivanovarkady endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT rozhchenkolarisa endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT petrovaanna endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT bhogalpervinder endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT cimpocaalexandru endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid
AT henkeshans endovasculartreatmentofchronicsubduralhematomasthroughembolizationapilotstudywithanonadhesiveliquidembolicagentofminimalviscositysquid